Clinical Professor of Medicine
Office Phone: 202-741-2233
- B.A Biology, Canisius College, 1976
- M. D., St. Louis University School of Medicine, 1980
James A. Sloand, MD, FACP, FASN is the Senior Global Medical Affairs Leader in the Cardio-Vascular Renal Metabolism Division at AstraZeneca Pharmaceuticals. He is also a Clinical Professor of Medicine within the Division of Kidney Diseases and Hypertension at George Washington University.
Dr. Sloand received his medical degree from St. Louis University School of Medicine, and completed his Internal medicine residency at St. Luke’s Hospital/Washington University in St. Louis, Missouri. Following residency, he finished a nephrology fellowship at the University of Rochester in Rochester, NY and remained on faculty with extensive clinical practice, academic and research work for 24 years, achieving the position of Professor of Medicine. Dr. Sloand is a Fellow of the American College of Physicians and a Fellow of the American Society of Nephrology. During his tenure at Baxter Healthcare Corporation from 2007-2018, his responsibilities as Global Therapeutic Area Lead for Peritoneal Dialysis included new product development, global expansion and life-cycle management for existing products, and global educational initiatives.
Dr. Sloand has authored or co-authored more than 70 peer-reviewed publications, four nephrology textbook chapters, and has has been an invited speaker at national and international nephrology congresses. He was recognized as “Best Teacher” within the faculty at the University of Rochester Department of Medicine over multiple years. When at Baxter, he directed a collaborative effort through the International Society of Peritoneal Dialysis to develop US, and later Global continuing medical educational programs dedicated to instructing surgeons, radiologists, and nephrologists in effective PD Catheter insertion techniques (PD catheter dysfunction being a prevalent reason for PD therapy failure).
Dr. Sloand served as a pioneer member on the board of directors for the Kidney Health Initiative, a collaboration including the FDA and the ASN dedicated to catalyzing “innovation and the development of safe and effective patient-centered therapies for people living with kidney diseases.” In 2017, Dr. Sloand received the John V. Heher Humanitarian Award from the National Kidney Foundation for “improving access to care for individuals with kidney disease and “outstanding dedication to the kidney community.”
Throughout his career, Jim has consistently educated, advocated and practiced his profession to improve the choices, medical care and quality of life for individuals with kidney disease.
View publications by this faculty member.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.